LXRX EPS Estimates
Lexicon Pharmaceuticals, Inc.
$1.57
-$0.08(-4.85%)
38
Overall
60
Value
9
Tech
47
Quality
Market Cap
$734.18M
Volume
729.23K
52W Range
$1.10 - $2.68
Target Price
$4.55
LXRX EPS estimates: the consensus estimate for Lexicon Pharmaceuticals, Inc.'s current fiscal year is -$0.17 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
LXRX EPS Estimates
- EPS estimate, current quarter
- $-0.05
- EPS estimate, next quarter
- $-0.04
- EPS estimate, current year
- $-0.17
- EPS estimate, next year
- $-0.24
- EPS growth, 3-year
- +39.11%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.14 |
| 2024 | $-0.63 |
| 2023 | $-0.80 |
| 2022 | $-0.62 |
| 2021 | $-0.60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LXRX | $1.57 | -4.8% | 729.23K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Lexicon Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW